ESPR Dividend History & Analysis | 0% Yield
ESPR has a dividend yield of 0% and paid 3.16 USD per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| NOVO-B CO Novo Nordisk |
221,835 M | 4.57% | 4.73% |
| ABBV NYSE AbbVie |
441,539 M | 3.21% | 6.86% |
| GILD NASDAQ Gilead Sciences |
167,413 M | 2.56% | 5.66% |
| AMGN NASDAQ Amgen |
196,249 M | 2.96% | 4.65% |
| AZN ST AstraZeneca |
295,487 M | 1.74% | 3.26% |
| HLN NYSE Haleon |
43,333 M | 1.93% | 2.69% |
| PHM MC Pharma Mar S.A. |
1,625 M | 1.23% | 1.45% |
| BIOA-B ST BioArctic (publ) |
2,951 M | 0.59% | 1.52% |
| ALK-B CO ALK-Abelló |
8,245 M | 0.75% | 1.09% |
| REGN NASDAQ Regeneron Pharmaceuticals |
70,027 M | 0.54% | 0.62% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| NOVO-B CO Novo Nordisk |
221,835 M | 26.23% | 100.0% |
| HLN NYSE Haleon |
43,333 M | 21.48% | 100.0% |
| PHM MC Pharma Mar S.A. |
1,625 M | 18.62% | 99.0% |
| AMGN NASDAQ Amgen |
196,249 M | 7.02% | 100.0% |
| ABBV NYSE AbbVie |
441,539 M | 5.22% | 100.0% |
| GILD NASDAQ Gilead Sciences |
167,413 M | 2.74% | 100.0% |
| REGN NASDAQ Regeneron Pharmaceuticals |
70,027 M | 6.24% | 100.0% |
| AZN ST AstraZeneca |
295,487 M | 3.77% | 100.0% |
ESPR Dividend History
Dividend Monthly Return EX date, 0 years of data
Average monthly dividend return by ex-dividend date. The score below shows reliability based on how consistently dividends were paid in that month.
| EX-DATE | RECORD | PAYMENT | PERIOD | DIV/SHARE | GROWTH | PAYOUT YIELD |
|---|---|---|---|---|---|---|
| 2026-07-13 | 3.16 | 0% | N/A |
ESPR Dividend FAQ
As of July 2026, ESPR's dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of 3.16 USD by the current share price of 3.18.
As of July 2026 ESPR does not pay a dividend.
ESPR pays dividends annually. Over the last 12 months, ESPR has issued 1 dividend payments. The last dividend payment was made on 2026-07-13.
Based on historical data, the forecasted dividend per share for ESPR for the next payment is 3.16 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about 99.4%.
The latest dividend paid per share was 3.16 USD with an Ex-Dividend Date of 2026-07-13. The next Ex-Dividend date for Esperion Therapeutics (ESPR) is currently unknown.
The next Ex-Dividend date for Esperion Therapeutics (ESPR) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
ESPR's average dividend growth rate over the past 5 years is 0.00% per year.
ESPR's 5-Year Yield on Cost is 17.9%. If you bought ESPR's shares at 17.68 USD five years ago, your current annual dividend income (3.16 USD per share, trailing 12 months) equals 17.9% of your original purchase price.
ESPR Payout Consistency is 100.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number. Very consistent: Esperion Therapeutics has a strong track record of consistent dividend payments over its lifetime.
ESPR's 0.00% Dividend Yield is considered as unknown.
The Dividend Payout Ratio of ESPR is unknown.
ESPR's Overall Dividend Rating is 17.50%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
ESPR Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-07-14 02:36 UTC